本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

5.40
-0.0900-1.64%
成交量:3,949.69万
成交额:2.20亿
市值:21.97亿
市盈率:-2.97
高:5.84
开:5.84
低:5.37
收:5.49
数据加载中...
2024/06/27

关联方拟减持公告

Form144 | Recursion Pharmaceuticals高管Tina Marriott拟减持6000股,总价约43290美元
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/25

关联方拟减持公告

Form144|Recursion Pharmaceuticals公司董事Blake Borgeson拟减持11447股,总价约108.8万美元
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

SEC问询函

Form CORRESP - Correspondence
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities